MoonLake Immunotherapeutics (MLTX) Ownership

42.19 ↓0.06 (-0.14%)
As of April 19, 2024, 3:59pm EST.

Institutional Ownership

Bvf Inc is the biggest individual institutional holder of MoonLake Immunotherapeutics (MLTX), owning a total of 21.8 million shares. Combined, the top 55 institutional holders of MLTX own 99.56% of the company with a total of 60.6 million shares.

In the latest ownership report on December 31st 2023, the top 55 institutional holders increased their combined ownership of MLTX by 3.5 million shares. 12 institutions bought 4,362,488 total additional shares and increased their ownership by an average of 46.99%. However 5 institutions sold 842,124 total shares and decreased their ownership by an average of 15.19%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of MoonLake Immunotherapeutics increased by a net total of 3,520,364 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Cormorant Asset Management, LLC13.510%4.324%8,494,151352,0512023-12-31
FMR Inc6.120%13.259%3,847,678450,4252023-12-31
venBio Select Advisor LLC4.103%29.000%2,580,000580,0012023-12-31
T. Rowe Price Associates, Inc.3.680%9.261%2,314,012196,1442023-12-31
Adage Capital Partners Gp LLC2.427%-21.866%1,525,717-426,9862023-12-31
T. Rowe Price Investment Management,Inc.1.941%0.484%1,220,6025,8792023-12-31
Federated Hermes Inc1.687%-2.188%1,060,526-23,7242023-12-31
Darwin Global Management, Ltd.1.653%0.000%1,039,2891,039,2892023-12-31
Polar Capital Holdings PLC1.490%-0.202%937,115-1,8972023-12-31
AllianceBernstein L.P.1.446%92.895%909,151437,8322023-12-31
Finepoint Capital LP1.424%170.053%895,000563,5842023-12-31
Fred Alger Management, LLC1.289%-2.685%810,586-22,3652023-12-31
Pictet Asset Manangement SA0.981%13.778%616,56374,6622023-12-31
Westfield Capital Management Company, LP0.973%56.423%612,050220,7712023-12-31
Balyasny Asset Management LLC0.952%155.501%598,510364,2602023-12-31
TimesSquare Capital Management, LLC0.777%18.869%488,80577,5902023-12-31
BlackRock Inc0.607%-49.027%381,726-367,1522023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Bvf Inc34.595%0.000%21,751,28402023-09-30
Cormorant Asset Management, LLC13.510%4.324%8,494,151352,0512023-12-31
FMR Inc6.120%13.259%3,847,678450,4252023-12-31
venBio Select Advisor LLC4.103%29.000%2,580,000580,0012023-12-31
T. Rowe Price Associates, Inc.3.680%9.261%2,314,012196,1442023-12-31
Citadel Advisors Llc3.236%0.682%2,034,39613,7882023-09-30
Adage Capital Partners Gp LLC2.427%-21.866%1,525,717-426,9862023-12-31
T. Rowe Price Investment Management,Inc.1.941%0.484%1,220,6025,8792023-12-31
Federated Hermes Inc1.687%-2.188%1,060,526-23,7242023-12-31
Darwin Global Management, Ltd.1.653%0.000%1,039,2891,039,2892023-12-31
TCG Crossover Management, LLC2.291%0.000%1,000,00002022-12-31
Polar Capital Holdings PLC1.490%-0.202%937,115-1,8972023-12-31
AllianceBernstein L.P.1.446%92.895%909,151437,8322023-12-31
Finepoint Capital LP1.424%170.053%895,000563,5842023-12-31
Fred Alger Management, LLC1.289%-2.685%810,586-22,3652023-12-31
Avidity Partners Management LP1.297%94.293%777,172377,1722023-09-30
Banque Pictet & Cie SA1.197%0.000%640,000640,0002023-06-30
Pictet Asset Manangement SA0.981%13.778%616,56374,6622023-12-31
Westfield Capital Management Company, LP0.973%56.423%612,050220,7712023-12-31
Balyasny Asset Management LLC0.952%155.501%598,510364,2602023-12-31
Integral Health Asset Management, LLC0.834%66.667%500,000200,0002023-09-30
RTW INVESTMENTS, LLC0.834%0.000%500,00002023-09-30
TimesSquare Capital Management, LLC0.777%18.869%488,80577,5902023-12-31
Wellington Management Company LLP0.706%2.448%423,38710,1182023-09-30
Artal Group S A0.748%0.000%400,000400,0002023-06-30
BlackRock Inc0.607%-49.027%381,726-367,1522023-12-31
Paradigm Biocapital Advisors LP0.691%0.000%369,615369,6152023-06-30
Schonfeld Strategic Advisors LLC0.542%188.827%340,700222,7402023-09-30
Point72 Asset Management, L.P.0.860%0.000%335,000335,0002022-09-30
JPMorgan Chase & Co0.567%576.171%303,222258,3782023-03-31
AXA SA0.563%-25.644%301,354-103,9302023-03-31
Tekla Capital Management LLC0.687%0.000%300,00002022-12-31
Great Point Partners LLC0.520%-56.684%278,334-364,2322023-03-31
TANG CAPITAL MANAGEMENT LLC0.563%-5.150%245,714-13,3402022-12-31
Ghost Tree Capital, LLC0.365%0.000%195,000195,0002023-03-31
Monashee Investment Management LLC0.492%-4.028%191,945-8,0552022-09-30
Sectoral Asset Management Inc0.345%0.000%184,590184,5902023-06-30
Amvescap Plc.0.331%0.000%176,770176,7702023-03-31
HighVista Strategies LLC0.229%0.000%122,201122,2012023-03-31
SILVERARC CAPITAL MANAGEMENT, LLC0.205%0.000%105,750105,7502023-03-31
Longwood Capital Partners LLC0.214%0.000%93,50093,5002022-12-31
Citigroup Inc0.150%-53.537%77,276-89,0412023-03-31
Granahan Investment Management Inc..0.169%0.000%73,63773,6372023-03-31
UBS Group AG0.168%-3.008%73,388-2,2762022-12-31
Ally Bridge Group (NY) LLC0.167%0.000%72,85072,8502023-03-31
Jefferies Financial Group Inc0.155%0.000%67,65467,6542022-12-31
TD Asset Management Inc0.154%0.000%67,31202022-12-31
TD Global Investment Solutions0.173%0.000%67,31202022-12-31
Barclays PLC0.128%270.961%55,95240,8692022-12-31
Cheyne Capital Management (UK) LLP..0.082%0.000%32,12932,1292022-12-31
Millennium Management LLC0.076%0.000%28,09028,0902022-06-30
ALPS Advisors Inc0.052%-35.560%20,144-11,1162022-09-30
COWEN AND COMPANY, LLC0.044%0.000%16,17316,1732022-06-30
Meridian Wealth Management, LLC0.039%-44.444%15,000-12,0002022-12-31
Renaissance Technologies Corp0.030%0.000%11,60911,6092022-12-31

Mutual Fund Ownership

T. Rowe Price Health Sciences is the biggest individual fund holder of MoonLake Immunotherapeutics (MLTX), owning a total of 1.1 million shares. Combined, the top 62 mutual fund holders of MLTX own 28.22% of the company with a total of 16.4 million shares.

In the latest ownership report on February 29th 2024, the top 62 fund holders increased their combined ownership of MLTX by 52 thousand shares. 1 funds bought 27,800 total additional shares and increased their ownership by an average of 9.13%. However 2 funds sold 79,322 total shares and decreased their ownership by an average of 5.78%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding MoonLake Immunotherapeutics decreased by a net total of -51,522 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Polar Capital Healthcare Opports Inc0.968%-11.507%608,772-79,1582024-02-29
Fidelity Contrafund0.788%0.000%495,23102024-02-29
Fidelity Blue Chip Growth0.631%0.000%396,52402024-02-29
Fidelity Growth Compy Commingled Pl O0.535%0.000%336,03402024-02-29
Fidelity Select Biotechnology0.529%9.126%332,44127,8002024-02-29
APO Medical Opportunities R0.480%0.000%302,07102024-02-29
AB Small Cap Growth A0.467%-0.056%293,352-1642024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price Health Sciences1.699%5.936%1,068,00759,8402023-12-31
T. Rowe Price New Horizons1.073%-0.319%674,911-2,1582023-12-31
US Small-Cap Growth II Equity Comp1.073%-0.319%674,911-2,1582023-12-31
Polar Capital Healthcare Opports Inc0.968%-11.507%608,772-79,1582024-02-29
Federated Hermes Kaufmann Growth0.883%0.000%555,00002023-12-31
Federated Hermes Kaufmann R0.883%0.000%555,00002023-12-31
Alger Small Cap Focus Composite0.854%-9.726%537,151-57,8722024-01-31
Alger Small Cap Focus I0.854%-9.726%537,151-57,8722024-01-31
Polar Capital Biotech S Inc0.968%-33.333%500,000-250,0002023-04-30
Fidelity Contrafund0.788%0.000%495,23102024-02-29
Fidelity® Contrafund®0.824%19.392%493,74080,1942023-10-31
Federated Hermes Kaufmann Small Cap A0.750%-5.745%471,276-28,7242023-12-31
Federated Hermes Kaufmann Small Cap Grow0.750%-5.745%471,276-28,7242023-12-31
MEDICAL BioHealth EUR Acc0.693%22.841%435,61981,0002023-11-30
Fidelity Advisor® Biotechnology I0.744%0.000%398,06202023-07-31
Fidelity Blue Chip Growth0.631%0.000%396,52402024-02-29
Fidelity® Blue Chip Growth0.662%-0.171%396,524-6792023-10-31
T. Rowe Price Small-Cap Stock0.620%-0.154%389,905-6002023-12-31
T. Rowe Price US Small-Cap Core Equity0.620%-0.154%389,905-6002023-12-31
Fidelity Growth Compy Commingled Pl 30.632%5.688%338,18818,2002023-07-31
Fidelity Growth Compy Commingled Pl O0.535%0.000%336,03402024-02-29
Fidelity Select Biotechnology0.529%9.126%332,44127,8002024-02-29
Pictet-Biotech P USD0.498%15.190%312,77541,2452023-10-31
Fidelity® Select Biotechnology0.513%-6.650%307,441-21,9002023-10-31
APO Medical Opportunities R0.480%0.000%302,07102024-02-29
AB Small Cap Growth A0.467%-0.056%293,352-1642024-02-29
Pictet-Global Megatrend Sel I USD0.476%23.663%285,03754,5422023-06-30
Fidelity Global Innovators Cl F0.450%-0.474%282,692-1,3472023-12-31
BlackRock Health Sciences Opps Inv A0.439%0.000%263,18902023-10-31
BlackRock Health Sciences Term Trust0.480%0.000%256,81602023-09-30
Fidelity® Series Small Cap Opps0.473%179.675%252,941162,5002023-07-31
Fidelity® Growth Company0.467%4.912%249,90011,7002023-07-31
BGF World Healthscience A20.597%0.000%233,79902022-12-31
BlackRock Health Sciences Trust II0.555%0.000%216,15002022-11-30
Vanguard Health Care Inv0.400%0.000%213,700213,7002023-06-30
Invesco DWA SmallCap Momentum ETF0.411%0.000%212,25202023-06-30
Invesco Dorsey Wright SmallCap Momt ETF0.380%0.336%203,1146812023-08-31
Harbor Small Cap Growth Instl0.389%0.000%200,852200,8522023-06-30
Westfield Capital Mgt Co Sm-Cap Gr Eq0.389%0.000%200,852200,8522023-06-30
T. Rowe Price Small-Cap Value0.350%0.000%180,986180,9862023-06-30
UTM IM GBP AXA Framlington Biotech0.287%-29.689%148,104-62,5382023-06-30
JPMorgan Small Cap Value I0.286%0.000%147,83802023-05-31
Principal SmallCap Growth I Instl0.260%0.000%113,550113,5502023-05-31
TD Health Sciences - I0.154%0.000%67,31202022-12-31
Lord Abbett Micro Cap Growth I0.124%0.000%54,18154,1812023-04-30
VALIC Company I Small Cap Value0.115%-4.976%50,228-2,6302023-04-30
Alger Small Cap Growth B0.103%0.000%44,97044,9702023-03-31
BrighthouseI JPMorgan Small Cap Value A0.093%590.272%40,58834,7082023-03-31
RIM Global Bioscience EUR0.079%4.716%34,3741,5482023-02-28
AST Small Cap Value0.075%0.000%32,81302023-04-30
T. Rowe Price Health Sciences Port0.070%-22.164%30,487-8,6812023-03-31
ALPS Medical Breakthroughs ETF0.060%0.000%23,33502022-11-30
AXA IM Wave Biotech A0.057%0.000%22,21102023-02-28
JHFunds2 Health Sciences NAV0.045%0.000%17,73602023-01-31
Fidelity® NASDAQ Composite Index®0.044%49.411%17,1095,6582023-02-28
BlackRock Health Sciences0.030%0.000%11,71502022-12-31
Pacific Select Health Sciences I0.026%0.000%10,00602022-12-31
EQ/T. Rowe Price Health Sciences IB0.023%78.611%9,0523,9842023-02-28
JHVIT Health Sciences I0.023%0.000%8,94702023-01-31
Thrivent Partner Healthcare0.016%0.000%6,19902022-12-31
apo Medical Opportunities Institutionell0.004%0.000%1,62902022-11-30
BlackRock Future Health ETF0.001%0.000%44502022-10-31

Discussions

Please log in or register to share your thoughts.

4texin

$MLTX Guys when can we expect that 30% drop?

0 Like Report
unknownable

$MLTX Dumping started...
Get out while you can...

0 Like Report
DivorceTiramisu

$MLTX I actually want the market pullback 5% is pretty crazy how this market keep going and going

0 Like Report
JohnDailyTrader

$MLTX Waiting waiting waiting — you know for what !!! Announcement!!!

0 Like Report
BroughtToMyKnees

$MLTX hang tight
ignore fud and buy dips if you can
everyone be okay????

0 Like Report
bulls_only

$MLTX I warned everyone this company sucks

0 Like Report